Target intelligence / Profile preview

Systemic immune and inflammatory pathways

Molecular classification
Other
01

Overview

Systemic immune and inflammatory pathways encompass the integrated network of cellular and molecular processes that mediate the body's response to internal and external stressors. These pathways involve the coordinated action of various immune cells, such as leukocytes and lymphocytes, and signaling molecules like cytokines, chemokines, and interferons [1][2]. While essential for host defense and tissue repair, chronic or excessive activation of these pathways is a primary driver of tissue damage in autoimmune disorders, metabolic syndromes, and cardiovascular diseases [3][4]. Pharmacological targeting of these pathways does not usually involve a single "systemic" receptor but rather focuses on specific high-impact nodes, such as Tumor Necrosis Factor-alpha (TNF-alpha) or Janus Kinases (JAK), to dampen the inflammatory cascade [5]. Consequently, while these pathways are central to therapeutic strategies, they represent a broad biological system rather than a discrete molecular target [6].

Other names
Systemic inflammationImmune signaling cascadesInflammatory pathwaysSystemic immune response
02

Mechanism of action

Inhibition or modulation of specific molecular components within the immune cascade, such as cytokines, receptors, or intracellular signaling kinases, to suppress overactive inflammatory responses.

03

Biological functions

Immune responseInflammationSignal transductionCell signalingHomeostasis
04

Disease associations

Autoimmune diseaseCancerCardiovascular diseaseInfectionSepsisChronic inflammatory diseases
05

Safety considerations

Increased susceptibility to opportunistic infectionsReactivation of latent tuberculosisMalignancy riskInfusion reactionsNeutropeniaCytokine release syndrome
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Erythrocyte sedimentation rate (ESR)Procalcitonin

Beyond the preview

Go deeper on Systemic immune and inflammatory pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systemic immune and inflammatory pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call